aTyr Pharma Receives FDA Fast Track Designation for Efzofitimod (ATYR1923) for Treatment of Pulmonary Sarcoidosis
Company is investigating efzofitimod in global pivotal Phase 3 EFZO-FITâ„¢ study in pulmonary sarcoidosis patients...
Love Hemp Group PLC Announces Directorate Changes and Trading Suspension Update
LONDON, UK / ACCESSWIRE / July 8, 2022 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF) the brand-led consumer goods company focussed on CBD health and wellness solutions, gives an update regarding its Board...
aTyr Pharma Announces FGFR4 as Receptor Target for AARS tRNA Synthetase Fragment
Poster to be presented at the Keystone Symposia on Tissue Fibrosis and Repair. Second tRNA synthetase receptor identified from company’s platform. ...